E-selectin S128R polymorphism and severe coronary artery disease in Arabs

Khaled K Abu-Amero1, Olayan M Al-Boudari, Gamal H Mohamed

  • 1Genetics Department, King Faisal Specialist Hospital and Research Centre (MBC-03), P, O, Box 3354, Riyadh 11211, Saudi Arabia. kamero@kfshrc.edu.sa

Insights

The E-selectin S128R polymorphism is linked to coronary artery disease (CAD) in Saudi Arabs. While univariate analysis showed an association, it was not significant in multivariate analysis for CAD risk factors.

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Molecular Biology

Background:

  • The E-selectin p. S128R (g. A561C) polymorphism has been linked to coronary artery disease (CAD) in various populations.
  • Limited data exists on the association between this E-selectin polymorphism and CAD in Arab populations.

Purpose of the Study:

  • To investigate the relevance of the E-selectin S128R polymorphism in severe CAD among Saudi Arabs.
  • To examine the association between this polymorphism and CAD risk factors in the Saudi population.

Main Methods:

  • Genotyping of Saudi Arabs for the E-selectin S128R polymorphism using PCR and restriction enzyme digestion.
  • Analysis of 556 patients with severe CAD and 237 angiographically confirmed control subjects.

Main Results:

  • The frequency of the mutant 128R allele was significantly higher in CAD patients (11%) compared to controls (6%) (OR=1.76, p=0.007).
  • Univariate analysis indicated a significant association between the 128R allele and CAD.
  • Multivariate analysis, including CAD risk factors, did not show a significant association for the 128R allele.

Conclusions:

  • The E-selectin p. S128R (g. A561C) polymorphism was associated with angiographic CAD in Saudi Arabs via univariate analysis.
  • This association was not maintained in multivariate analysis when considering CAD risk factors.
Abstract

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Selectins01:25

Selectins

Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...